Navigation Links
PAREXEL Announces Date of First Quarter Fiscal Year 2008 Earnings Release and Conference Call
Date:10/3/2007

BOSTON, Oct. 3 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (Nasdaq: PRXL) will release First Quarter Fiscal Year 2008 financial results on Wednesday, October 24, 2007 after the close of the stock market. The announcement will be available on PAREXEL's website at http://www.parexel.com and on the PR Newswire website at http://www.prnewswire.com.

PAREXEL will host a conference call and live webcast at 10:00 a.m. ET on Thursday, October 25, 2007 to discuss the results. To access the webcast, visit PAREXEL's website at http://www.parexel.com, click on the Investors menu. This webcast will continue to be accessible for one year following the live broadcast. To participate via telephone, dial (612) 332-0228 and ask to join PAREXEL's First Quarter Fiscal Year 2008 conference call.

About the Company

PAREXEL International Corporation is a leading global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, medical communications and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the c
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2008)...e than 20 world experts on building sustainable ci... will converge in Singapore on 21-22 Oct. 2008 for...hey will share creative insights and solutions to ...ities in the future. , World-renowned futurist... Michio Kaku, Ph.D., is the keynote speaker, addre...
(Date:9/3/2008)...ADISON, N.J., Sept. 3 /- Wy...of Daniel J. McIntyre, 54, to Vice,President, Corp..., Senior,Vice President, Corporate Affairs, Mr. Mc...ternal communications for the corporation and its ... health care and animal health,-- around the world...
(Date:9/3/2008)...HELMSFORD, Mass., Sept. 3 /- ESA Bios... in novel HPLC detection systems that improve,resu... science, and,analytical-chemistry customers world...t & Sullivan North American Technology Innovation ...ems. Frost & Sullivan will present the,award to ES...
(Date:9/3/2008)...ILVER SPRING, Md., Sept. 3 /PRNewswire-FirstCall/ ...) and its wholly-owned subsidiary,Lung Rx, Inc. an...ration,(FDA) has accepted for review the New Drug ... treatment of pulmonary arterial hypertension. The...f 10 months, with a targeted,user fee deadline of ...
Breaking Biology Technology:Singapore to hold international 'pow-wow' 2Singapore to hold international 'pow-wow' 3Wyeth Names Daniel J. McIntyre Vice President, Corporate Communications 2ESA Receives 2008 Frost & Sullivan North American Technology Innovation Award for Development of Integrated Metabolomics Systems 2ESA Receives 2008 Frost & Sullivan North American Technology Innovation Award for Development of Integrated Metabolomics Systems 3
...arian, Inc. , Introduction , Te...evalent in various environments, including forensi...porting events. Non-heroin opiates such as morphin...singly in drug indicator data. For example, in San...tions of oxycodone overdose increased 110 percent ...
...luorescent Protein (GFP) and its derivatives , ...tion in vivo using , the Varian Cary Ecli....D , Daren J. Fyfe, Ph.D * , #... Monash University, , Clayton campus Vict...ance: Varian Australia Pty Ltd, Mulgrave, Victoria...
...gricultural chemicals typically analyzed by GC/MS ...and efficiently using LC/MS/MS. These agricultural... thereby present matrix challenges. , Ove...ions worldwide are placing great importance on the...nd herbicides in produce. Chlorinated pesticides h...
...e Expression (SAGE) is a sequence-based approach t...enes by comparative analyses. SAGE is a powerful t...le for detailed analysis of large numbers of cellu...ssed genes. 1 SAGE provides an accurate quantitat...ssed in a specimen. The ability to count many thou...
Other Biology Technology:Detection of Morphine and Morphine-Glucuronide in Saliva or Urine with a Rapid and Simple Method Without Derivatization on the Varian 500-MS 2Detection of Morphine and Morphine-Glucuronide in Saliva or Urine with a Rapid and Simple Method Without Derivatization on the Varian 500-MS 3Detection of Morphine and Morphine-Glucuronide in Saliva or Urine with a Rapid and Simple Method Without Derivatization on the Varian 500-MS 4Cytosolic expression of Green Fluorescent Protein (GFP) and its derivatives , in the yeast Saccharomyces cerevisiae: Detection in vivo using , the Varian Cary Eclipse 2Cytosolic expression of Green Fluorescent Protein (GFP) and its derivatives , in the yeast Saccharomyces cerevisiae: Detection in vivo using , the Varian Cary Eclipse 3Cytosolic expression of Green Fluorescent Protein (GFP) and its derivatives , in the yeast Saccharomyces cerevisiae: Detection in vivo using , the Varian Cary Eclipse 4Cytosolic expression of Green Fluorescent Protein (GFP) and its derivatives , in the yeast Saccharomyces cerevisiae: Detection in vivo using , the Varian Cary Eclipse 5Identification of Insecticides and Herbicides by LC/MS/MS Using the API 2000 LC/MS/MS System 2Serial Analysis of Gene Expression Using ABI PRISM DNA Sequencers and BigDye Terminators 2Serial Analysis of Gene Expression Using ABI PRISM DNA Sequencers and BigDye Terminators 3Serial Analysis of Gene Expression Using ABI PRISM DNA Sequencers and BigDye Terminators 4Serial Analysis of Gene Expression Using ABI PRISM DNA Sequencers and BigDye Terminators 5
(Date:9/4/2008)...hode Island Hospital found that obesity and Type 2...eurodegeneration with features common with Alzheim...esity can cause neurodegeneration. The study appea... 15:1 (September 2008) . , In a study on animal...MPH, of Rhode Island Hospital, utilized chronic hi...
(Date:9/3/2008)...2008) The tumor suppressor gene pRb2/p130 may pro... cases of soft tissue sarcoma (STS), according to ...luding scientists at the Sbarro Institute for Canc...of Science and Technology at Temple University in ...y and Oncology, University of Siena and the Center...
(Date:9/3/2008)...sity of Texas Medical Branch at Galveston research...process by which the Ebola Zaire virus infects cel...deadly disease produced by the virus. , Ebola pr... its victims and inflicts mortality rates close to...iral therapy has been developed against the virus,...
(Date:9/3/2008)...ll be able to receive the same type of medical tre...ina State University becomes the first university ...nts in a clinical setting. , Dr. Steven Suter, a...ge of Veterinary Medicine, received three leukopho...ster, Minn. Leukophoresis machines are designed to...
Breaking Biology News(10 mins):International team reveals first prognosticator of survival in aggressive cancer 2Scientists uncover Ebola cell-invasion strategy 2NC State first university in nation to offer canine bone marrow transplants 2Semafores PI3 Kinase Inhibitor SF1126 is a Vascular Targeted Conjugate in Phase I Clinical Trials in Solid Tumors and Multiple Myeloma 1766 1Semafores PI3 Kinase Inhibitor SF1126 is a Vascular Targeted Conjugate in Phase I Clinical Trials in Solid Tumors and Multiple Myeloma 1766 2Hearts Stem Cells Not Created Equally 16713 1Hearts Stem Cells Not Created Equally 16713 2Celebrex Lipitor combo may halt prostate cancer 16711 1Celebrex Lipitor combo may halt prostate cancer 16711 2Celebrex Lipitor combo may halt prostate cancer 16711 3Blood pressure drugs halt pancreatic cancer cell growth Jefferson researchers find 16709 1Blood pressure drugs halt pancreatic cancer cell growth Jefferson researchers find 16709 2
... uses different pathways to invade red blood cell...ng efforts to create effective vaccines against th... F. Cowman, an international research scholar with...ed a gene that the parasite uses to switch back an...from the Scripps Research Institute in La Jolla, C...
...d a process that has stumped scientists for many y...nters a cell,s nucleus, where it has strong anti-c...ansport mechanism opens a new door for future rese...nt implications for the fight against cancer and o...recent issue of the journal Molecular Cell (Vol. 1...
...d disease porphyria , Dana-Farber Cancer Institut...explanation for the episodic attacks of irrational...elieved to have afflicted "Mad" King George III, t...an colonies in the Revolutionary War. , The mental...c blood disease which a number of modern researche...
...f Oregon scientists to replicate an extreme range ... and understand the human body,s response to every...ental chamber, is a 12-foot-square room capable of...mperature constant at a set point between 14 and 1...ywhere from 10 to 95 percent. The chamber is so fi...
Other Biology News:Gene expands malaria's invasion options 2Gene expands malaria's invasion options 3Study shows how retinoic acid enters a cell's nucleus 2Study shows how retinoic acid enters a cell's nucleus 3Attacks of King George III's madness linked to key metabolism molecule 2Attacks of King George III's madness linked to key metabolism molecule 3Going To Extremes To Improve Human Health 2
... components used for alkaline phosphatase activity...tibodies required to perform 100 tests (including ...ct of extensive investigation recently, partly due...aise several fundamental issues concerning the reg...
Preparation Note: Prepared by a modification of the procedure of Hancher, C.W., et al., Biotechnol. Bioeng., 11 , 1055 (1969). Unit Definition: One unit will yield an A 260 of 1.0 in 1.0 ml of wat
1,4-Dithiothreitol DTT White crystalline solid. PACKAGED UNDER INERT GAS. Purity: ≥99% by titration. Contaminants: DNases, proteases, RNases: none detected. Absorbance (100 mM, 1 cm, 260 nm
...s specifically designed for location analysis of y...ng chromatin immunoprecipitation (ChIP) with Agile...dization and reliable binding data with greater tr...dition, Agilent provides flexibility by offering b...
Biology Products: